SIM
ARNA

SummerHaven Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SummerHaven Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,409
Closed -$437K – 322
2021
Q2 		$437K Buy
6,409
+158
+3% +$10.3K 0.25% 190
2021
Q1 		$434K Hold
6,251
– – 0.26% 196
2020
Q4 		$480K Buy
+6,251
New +$469K 0.37% 181

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

SummerHaven Investment Management's ARNA Position: Q3 2021 in Review

SummerHaven Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 6,409 shares — an estimated $437K sold.

SummerHaven Investment Management first reported a position in ARNA in Q4 2020 and held it in 3 quarters. The position peaked at $480K in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • SummerHaven Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • SummerHaven Investment Management sold 6,409 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $437K.
  • SummerHaven Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 3 quarters.
  • SummerHaven Investment Management's Arena Pharmaceuticals Inc position peaked at $480K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on SummerHaven Investment Management's 13F filing for Q3 2021, filed 20 Oct 2021.